Notice 30 Apr 2025 transportation, united states, railroad, labor, compliance, regulatory

🚆FRA Notice

This document provides the public notice that Long Island Rail Road (LIRR) petitioned FRA for an extension of relief from certain regulations concerning hours of service.

Learn More
Notice 30 Apr 2025 infectious diseases, business opportunities, grants, health, nih, regulatory

💰NIH Meeting on Grant Applications for Allergy and Infectious Diseases

The notice outlines a public meeting of the National Advisory Allergy and Infectious Diseases Council, including details on grant evaluations related to allergy and infectious diseases. Closed sessions will discuss confidential information, while open sessions will report on activities from Division Directors. Public participation and comments are encouraged.

Learn More
Notice 30 Apr 2025 meeting, nih, health, regulatory, business, research

🏥Notice of NIH Clinical Center Research Hospital Board Meeting

This notice announces a hybrid meeting of the NIH Clinical Center Research Hospital Board, detailing the agenda, date, and contact information for interested participants. It highlights opportunities for public comment and emphasizes the necessity for special assistance requests, ensuring accessibility for all attendees. The meeting will focus on leadership updates and other business matters relevant to health research.

Learn More
Notice 29 Apr 2025 regulatory, meeting, safety, compliance, highway, transportation, ntsb

🚧NTSB Sunshine Act Meeting on Highway Investigation Report

The National Transportation Safety Board is hosting a Sunshine Act meeting to discuss a highway investigation report concerning a July 2023 collision involving motorcoaches. The meeting is open to the public and will provide insights into ongoing transportation safety evaluations and regulatory considerations.

Learn More
Notice 29 Apr 2025 business partnerships, regulatory, national science foundation, federal funding, artificial intelligence, research and development

🤖Input Request for 2025 National AI R&D Strategic Plan

On behalf of the Office of Science and Technology Policy (OSTP), the Networking and Information Technology Research and Development (NITRD) National Coordination Office (NCO) welcomes input from all interested parties on how the previous administration's National Artificial Intelligence Research and Development Strategic Plan (2023 Update) can be rewritten so that the United States can secure its position as the unrivaled world leader in artificial intelligence by performing R&D to accelerate AI-driven innovation, enhance U.S. economic and national security, promote human flourishing, and maintain the United States' dominance in AI while focusing on the Federal government's unique role in AI research and development (R&D) over the next 3 to 5 years. Through this Request for Information (RFI), the NITRD NCO encourages the contribution of ideas from the public, including AI researchers, industry leaders, and other stakeholders directly engaged in or affected by AI R&D. Responses previously submitted to the RFI on the Development of an AI Action Plan will also be considered in updating the National AI R&D Strategic Plan.

Learn More
Notice 29 Apr 2025 regulatory, reactor safeguards, advisory committee, public participation, compliance, nuclear

⚛️2025 NRC Advisory Committee Meeting Procedures and Business Implications

This notice outlines procedures for meetings conducted by the U.S. Nuclear Regulatory Commission's Advisory Committee on Reactor Safeguards. It emphasizes public participation protocols, including submission of comments and virtual attendance options, ensuring stakeholder engagement on nuclear safety matters and licensing applications.

Learn More
Notice 28 Apr 2025 controlled substances, regulatory, business registration, compliance, drug enforcement

⚖️VHG Labs Controlled Substances Import Application Overview

VHG Labs DBA LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Learn More
Notice 28 Apr 2025 dtm interstate transportation, regulatory, accounting, finance, federal, energy, acquisitions

📈Combined Notice of Filings for Energy Company Acquisitions

The Federal Energy Regulatory Commission has published a notice regarding multiple accounting requests for proposed journal entries related to the acquisitions of energy companies by DTM Interstate Transportation, LLC. Business owners and executives are encouraged to review these filings and engage in the comment process if applicable.

Learn More
Notice 28 Apr 2025 reporting, regulatory, usda, compliance, agriculture, dairy

🧀Notice on Dairy Product Reporting Program Extension

In accordance with the Paperwork Reduction Act of 1995, this notice announces the Agricultural Marketing Service's (AMS) intention to request an extension and revision of a currently approved information collection under the Dairy Product Mandatory Reporting Program. The information collected supports the marketing of dairy products and is used to verify compliance with Federal milk marketing regulations.

Learn More
Notice 25 Apr 2025 sec, investment, regulatory, business development companies, financial services

📈SEC Exemption Notice for KKR FS Income Trust Investment Class Shares

The Securities and Exchange Commission (SEC) issues a notice regarding KKR FS Income Trust's application for an exemption under the Investment Company Act. This would allow certain investment companies to issue multiple classes of shares, each with varying fees. The content includes details on applicant representation and the process required for public hearing requests.

Learn More